verapamil has been researched along with Abdominal Migraine in 54 studies
Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ninety patients, 50 males and 40 females, and their ages ranged between 42 and 70 years, with severe hypertension were treated by either sublingual verapamil tablets 40 mg (30 patients) or 80 mg (30 patients) or sublingual nifedipine capsules 10 mg (30 patients)." | 7.70 | Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine. ( Al-Waili, NS; Hasan, NA, 1999) |
| "To describe the use of intravenous verapamil in a migraine patient with hemiplegia to reverse the symptomatology and hemodynamics of the middle cerebral artery as determined by transcranial Doppler." | 7.70 | The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia. ( Fagan, SC; Geiszt, G; Kohli, A; Mohamed, AE; Ng, TM, 2000) |
| "Flunarizine's effect in migraine probably involves monoamine mechanisms which bear no relation to calcium." | 3.77 | [Calcium channel blockers and prevention of migraine]. ( Montastruc, JL; Senard, JM, 1992) |
| "Verapamil is a papaverine derivative calcium channel blocking drug that has been effectively utilized in the prophylaxis of migraine." | 3.76 | Verapamil in migraine prophylaxis--a five-year review. ( Solomon, GD, 1989) |
| "Ninety patients, 50 males and 40 females, and their ages ranged between 42 and 70 years, with severe hypertension were treated by either sublingual verapamil tablets 40 mg (30 patients) or 80 mg (30 patients) or sublingual nifedipine capsules 10 mg (30 patients)." | 3.70 | Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine. ( Al-Waili, NS; Hasan, NA, 1999) |
| "To describe the use of intravenous verapamil in a migraine patient with hemiplegia to reverse the symptomatology and hemodynamics of the middle cerebral artery as determined by transcranial Doppler." | 3.70 | The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia. ( Fagan, SC; Geiszt, G; Kohli, A; Mohamed, AE; Ng, TM, 2000) |
| "Mean almotriptan peak concentration and area under the plasma concentration-time curve were significantly higher and volume of distribution and oral clearance were significantly lower after coadministration of almotriptan and verapamil compared with administration of almotriptan alone." | 2.69 | Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers. ( Azie, NE; Carel, BJ; Fleishaker, JC; Sisson, TA, 2000) |
| "The efficacy of verapamil CR in migraine prophylaxis has been tested in an open study with 64 patients." | 2.67 | [The use of verapamil in the treatment of hemicrania without aura]. ( Farinini, D; Fonzari, M; Santoloci, D, 1994) |
| "Ten of the 12 patients had fewer migraines during verapamil therapy." | 2.65 | Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study. ( Solomon, GD; Spaccavento, LJ; Steel, JG, 1983) |
| "Neurologists and PCPs chose migraine prophylaxis on the basis of scientific merit (r = 0." | 2.40 | Migraine prophylactic drugs: proof of efficacy, utilization and cost. ( Gilkey, SJ; Ramadan, NM; Schultz, LL, 1997) |
| "Acute therapy for athletes with migraines is best managed with sumatriptan or DHE 45 and prophylaxis can be accomplished with verapamil, antidepressants, or valproate." | 2.40 | Diagnosis, prophylaxis, and treatment of headaches in the athlete. ( Kaplan, B; Swain, RA, 1997) |
| "Women with migraine often experience a worsening of symptoms at menopause." | 2.39 | Approach to the patient with migraine. ( Baringer, JR; Raskin, NH, 1996) |
| "The majority of patients with hyperacusis demonstrated symptomatic improvement from migraine prophylaxis therapy, as indicated by self-reported and audiometric measures." | 1.56 | Efficacy of Multi-Modal Migraine Prophylaxis Therapy on Hyperacusis Patients. ( Abouzari, M; Djalilian, HR; Ghavami, Y; Goshtasbi, K; Lin, HW; Parker, EM; Sarna, B; Tan, D, 2020) |
| "The mean pre-treatment Dizziness Handicap Inventory score was 57." | 1.56 | Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine. ( Donaldson, L; Dornhoffer, JR; Liu, YF; Macias, D; Rizk, HG, 2020) |
| "Management of MdDS as vestibular migraine can improve patients' symptoms and increase the QOL." | 1.46 | Management of mal de debarquement syndrome as vestibular migraines. ( Bhatt, J; Djalilian, HR; Ghavami, Y; Haidar, YM; Lin, HW; Moshtaghi, O; Ziai, KN, 2017) |
| "We report a patient with a history of migraine without aura who developed cluster headache and HC simultaneously." | 1.36 | Coexisting trigeminal autonomic cephalalgias and hemicrania continua. ( Grosberg, BM; Lipton, RB; Robbins, MS, 2010) |
| "We believe that surgical treatment of migraine headaches may be a realistic option for these patients." | 1.35 | Review of pediatric migraine headaches refractory to medical management. ( Eshraghi, Y; Gosain, AK; Kung, TA; Scher, MS; Totonchi, A, 2009) |
| "Abdominal migraine usually has its onset during childhood or adolescence and resolves in adulthood, often being replaced by typical migraine headaches." | 1.35 | Rebound abdominal pain: noncephalic pain in abdominal migraine is exacerbated by medication overuse. ( Newman, EB; Newman, LC, 2008) |
| "Chronic cluster headache was diagnosed, and he was given verapamil, 360 mg per day." | 1.31 | Simultaneous occurrence of ipsilateral cluster headache and chronic paroxysmal hemicrania: a case report. ( Albano, O; Bassi, A; Causarano, V; Centonze, A; Centonze, V; Dalfino, L, 2000) |
| "It is known that exertion can aggravate migraine headache." | 1.31 | Hemiplegic migraine induced by exertion. ( Adams, HP; Afifi, A; Fattal, D; Razavi, B; Razavi, M, 2000) |
| "Cluster headache is a rare but very typical disease." | 1.30 | [Cluster headache: misjudged because unknown]. ( Koudstaal, PJ; Ridderikhoff, J, 1997) |
| "After two days of complete remission, cluster headache attacks reappeared and persisted until verapamil, 360 mg a day, was added to indomethacin." | 1.28 | Ipsilateral cluster headache and chronic paroxysmal hemicrania: two case reports. ( Bousser, MG; Tehindrazanarivelo, AD; Visy, JM, 1992) |
| "The interactions of four abortive anti-migraine agents and four prophylactic anti-migraine agents with 5-HT1D receptors in bovine brain were analyzed using radioligand binding techniques and adenylate cyclase assays." | 1.28 | 5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy. ( Deliganis, AV; Peroutka, SJ, 1991) |
| "In subjects with known migraine, the occurrence of chest pain may represent coronary artery spasm, and should be investigated with concurrent electrocardiographs, as these two clinical entities may be related as part of a generalised vasospastic disorder." | 1.27 | A possible relationship between migraine and coronary artery spasm. ( Wayne, VS, 1986) |
| "Migraine is among the most common disorders seen in office practice." | 1.27 | Management of the migraine patient. ( Gunderson, CH, 1986) |
| "It is postulated that, in migraine, calcium entry blockers may prevent exaggerated responses to catecholaminergic stimulation." | 1.27 | Pupillary and vascular effects of calcium antagonists in migraine. ( Boccuni, M; Cangi, F; Fanciullacci, M; Fusco, BM; Gatto, G; Marabini, S; Pietrini, U, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (27.78) | 18.7374 |
| 1990's | 17 (31.48) | 18.2507 |
| 2000's | 13 (24.07) | 29.6817 |
| 2010's | 6 (11.11) | 24.3611 |
| 2020's | 3 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Abouzari, M | 1 |
| Tan, D | 1 |
| Sarna, B | 1 |
| Ghavami, Y | 3 |
| Goshtasbi, K | 1 |
| Parker, EM | 1 |
| Lin, HW | 3 |
| Djalilian, HR | 3 |
| Liu, YF | 1 |
| Macias, D | 1 |
| Donaldson, L | 1 |
| Dornhoffer, JR | 1 |
| Rizk, HG | 1 |
| Cutrer, FM | 1 |
| Moyer, AM | 1 |
| Atkinson, EJ | 1 |
| Wang, L | 1 |
| Tian, S | 1 |
| Wu, Y | 1 |
| Garza, I | 1 |
| Robertson, CE | 1 |
| Huebert, CA | 1 |
| Moore, BE | 1 |
| Klein, CJ | 1 |
| Haidar, YM | 2 |
| Moshtaghi, O | 2 |
| Kaya, I | 1 |
| Eraslan, S | 1 |
| Tarhan, C | 1 |
| Bilgen, C | 1 |
| Kirazli, T | 1 |
| Gokcay, F | 1 |
| Karapolat, H | 1 |
| Celebisoy, N | 1 |
| Carr, E | 1 |
| Joudeh, L | 1 |
| Ziai, KN | 1 |
| Bhatt, J | 1 |
| Kung, TA | 1 |
| Totonchi, A | 1 |
| Eshraghi, Y | 1 |
| Scher, MS | 1 |
| Gosain, AK | 1 |
| Robbins, MS | 1 |
| Grosberg, BM | 1 |
| Lipton, RB | 2 |
| Chu, ER | 1 |
| Lee, AW | 1 |
| Chen, CS | 1 |
| Kayan, M | 1 |
| Nazıroğlu, M | 1 |
| Ovey, IS | 1 |
| Aykur, M | 1 |
| Uğuz, AC | 1 |
| Yürekli, VA | 1 |
| Gilbert, GJ | 1 |
| Dora, B | 1 |
| Lisotto, C | 1 |
| Mainardi, F | 1 |
| Maggioni, F | 1 |
| Zanchin, G | 1 |
| Ducros, A | 1 |
| Newman, LC | 2 |
| Newman, EB | 1 |
| Solomon, GD | 4 |
| Steel, JG | 1 |
| Spaccavento, LJ | 1 |
| Meyer, JS | 1 |
| Hardenberg, J | 1 |
| Peroutka, SJ | 2 |
| Markley, HG | 2 |
| Cheronis, JC | 1 |
| Piepho, RW | 1 |
| Prusiński, A | 2 |
| Fonzari, M | 1 |
| Santoloci, D | 1 |
| Farinini, D | 1 |
| Raskin, NH | 1 |
| Baringer, JR | 1 |
| Ridderikhoff, J | 1 |
| Koudstaal, PJ | 1 |
| Ramadan, NM | 1 |
| Schultz, LL | 1 |
| Gilkey, SJ | 1 |
| Swain, RA | 1 |
| Kaplan, B | 1 |
| Al-Waili, NS | 1 |
| Hasan, NA | 1 |
| Ng, TM | 1 |
| Kohli, A | 1 |
| Fagan, SC | 1 |
| Mohamed, AE | 1 |
| Geiszt, G | 1 |
| Centonze, V | 3 |
| Bassi, A | 1 |
| Causarano, V | 1 |
| Dalfino, L | 1 |
| Centonze, A | 1 |
| Albano, O | 3 |
| Fleishaker, JC | 1 |
| Sisson, TA | 1 |
| Carel, BJ | 1 |
| Azie, NE | 1 |
| Rankin, LM | 1 |
| Bruhl, M | 1 |
| Evans, RW | 1 |
| Solomon, S | 1 |
| Razavi, M | 1 |
| Razavi, B | 1 |
| Fattal, D | 1 |
| Afifi, A | 1 |
| Adams, HP | 1 |
| Mariani, C | 1 |
| Farina, E | 1 |
| Scarlato, G | 1 |
| Montastruc, JL | 1 |
| Senard, JM | 1 |
| Tehindrazanarivelo, AD | 1 |
| Visy, JM | 1 |
| Bousser, MG | 1 |
| Deliganis, AV | 1 |
| Taylor, MD | 1 |
| McQueen, KD | 1 |
| Solomon, SS | 1 |
| Torres, C | 1 |
| Altus, P | 1 |
| Lastilla, M | 1 |
| Achille, P | 1 |
| Savarese, MA | 1 |
| Frascella, G | 1 |
| Paterna, S | 1 |
| Martino, SG | 1 |
| Campisi, D | 1 |
| Cascio Ingurgio, N | 1 |
| Marsala, BA | 1 |
| Greenberg, DA | 1 |
| Wayne, VS | 1 |
| Molaie, M | 1 |
| Olson, CM | 1 |
| Koch, J | 1 |
| Campanozzi, F | 2 |
| Macinagrossa, G | 2 |
| Attolini, E | 2 |
| Magrone, D | 2 |
| Tesauro, P | 2 |
| Vino, M | 1 |
| Kozubski, W | 1 |
| Trizio, T | 1 |
| Altomare, E | 1 |
| Gunderson, CH | 1 |
| Fanciullacci, M | 1 |
| Boccuni, M | 1 |
| Pietrini, U | 1 |
| Cangi, F | 1 |
| Gatto, G | 1 |
| Marabini, S | 1 |
| Fusco, BM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Verapamil as Adjunctive Seizure Therapy for Children and Young Adults With Dravet Syndrome[NCT01607073] | Phase 2 | 2 participants (Actual) | Interventional | 2012-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The secondary outcome measure is the change in number of absence seizures from Week 8 (Baseline) to Week 12 (NCT01607073)
Timeframe: Week 8 to Week 12
| Intervention | Abscence seizures (Number) |
|---|---|
| Week 8 Baseline | 165 |
| Week 12 Verapamil 4mg/kg/Day | 101 |
The primary study endpoint is the change in number of seizures from baseline. Since we only had one participant finish the study, the endpoint was changed to Week 12 visit. Participants were on verapamil for 4 weeks at Week 12. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | General tonic-clonic seizures (Number) |
|---|---|
| Week 8 Baseline | 39 |
| Week 12 Verapamil 4mg/kg/Day | 14 |
The secondary outcome is the change in number of myoclonic seizures between baseline Week 8 visit and Week 12 visit. (NCT01607073)
Timeframe: Week 8 (baseline) to Week 12
| Intervention | Myoclonic seizures (Number) |
|---|---|
| Week 8 Baseline | 116 |
| Week 12 Verapamil 4mg/kg/Day | 175 |
12 reviews available for verapamil and Abdominal Migraine
| Article | Year |
|---|---|
[Acute and chronic headaches].
Topics: Acetaminophen; Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Aspir | 2006 |
[Present problems of migraine and similar headaches].
Topics: Brain; Cranial Nerves; Humans; Migraine Disorders; Neurotransmitter Agents; Stress, Psychological; S | 1994 |
Approach to the patient with migraine.
Topics: Analgesics, Non-Narcotic; Antipyrine; Chloral Hydrate; Drug Combinations; Drug Therapy, Combination; | 1996 |
Migraine prophylactic drugs: proof of efficacy, utilization and cost.
Topics: Adult; Amitriptyline; Female; Humans; Male; Migraine Disorders; Propranolol; Verapamil | 1997 |
Diagnosis, prophylaxis, and treatment of headaches in the athlete.
Topics: Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents, Tricyclic; | 1997 |
[Calcium channel blockers and prevention of migraine].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Diltiazem; Flunarizine; Humans; Migraine Diso | 1992 |
Verapamil as migraine prophylaxis.
Topics: Humans; Migraine Disorders; Verapamil | 1991 |
Prophylactic therapy of cluster headaches.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cluster Headache; Humans; Lithium; Lithium Carbonate; Methy | 1991 |
Verapamil and migraine prophylaxis: mechanisms and efficacy.
Topics: Animals; Chronic Disease; Clinical Trials as Topic; Cluster Headache; Humans; Migraine Disorders; Re | 1991 |
Calcium channel antagonists and the treatment of migraine.
Topics: Calcium; Calcium Channel Blockers; Cinnarizine; Diltiazem; Flunarizine; Humans; Ion Channels; Kineti | 1986 |
Verapamil in migraine prophylaxis--a five-year review.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Verapamil | 1989 |
Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine.
Topics: Calcium Channel Blockers; Cinnarizine; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Flu | 1985 |
12 trials available for verapamil and Abdominal Migraine
| Article | Year |
|---|---|
Verapamil prophylaxis of migraine. A double-blind, placebo-controlled study.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Placebos; Random Allocati | 1983 |
Clinical effectiveness of calcium entry blockers in prophylactic treatment of migraine and cluster headaches.
Topics: Adult; Calcium Channel Blockers; Cerebrovascular Circulation; Clinical Trials as Topic; Cluster Head | 1983 |
The pharmacology of calcium channel antagonists: a novel class of anti-migraine agents?
Topics: Calcium Channel Blockers; Cerebrovascular Circulation; Clinical Trials as Topic; Cyproheptadine; Dil | 1983 |
Verapamil in prophylactic therapy of migraine.
Topics: Adult; Aged; Female; Humans; Male; Middle Aged; Migraine Disorders; Verapamil | 1984 |
[The use of verapamil in the treatment of hemicrania without aura].
Topics: Adolescent; Adult; Chronic Disease; Female; Follow-Up Studies; Humans; Incidence; Italy; Male; Middl | 1994 |
Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers.
Topics: Adolescent; Adult; Analysis of Variance; Blood Pressure; Calcium Channel Blockers; Chromatography, H | 2000 |
[Calcium channel blockers and prevention of migraine].
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Diltiazem; Flunarizine; Humans; Migraine Diso | 1992 |
[Verapamil versus flunarizine in the preventive therapy of hemicrania].
Topics: Adolescent; Adult; Drug Evaluation; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorde | 1990 |
[Evaluation of the effects of verapamil, flunarizine, diltiazem, nimodipine and placebo in the prevention of hemicrania. A double-blind randomized cross-over study].
Topics: Adolescent; Adult; Diltiazem; Double-Blind Method; Female; Flunarizine; Humans; Male; Middle Aged; M | 1990 |
Verapamil in migraine prophylaxis--a five-year review.
Topics: Clinical Trials as Topic; Double-Blind Method; Humans; Migraine Disorders; Verapamil | 1989 |
The effect of intravenous verapamil on acute migraine headache.
Topics: Acute Disease; Adult; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Injections, Int | 1987 |
Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine.
Topics: Calcium Channel Blockers; Cinnarizine; Clinical Trials as Topic; Diltiazem; Double-Blind Method; Flu | 1985 |
33 other studies available for verapamil and Abdominal Migraine
| Article | Year |
|---|---|
Efficacy of Multi-Modal Migraine Prophylaxis Therapy on Hyperacusis Patients.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Anticonvulsants; Drug Therapy, Combination; Female; Follo | 2020 |
Pharmacotherapy failure and progression to botulinum toxin injection in vestibular migraine.
Topics: Adult; Aged; Aged, 80 and over; Botulinum Toxins; Dizziness; Female; Humans; Injections; Male; Middl | 2020 |
Genetic variants related to successful migraine prophylaxis with verapamil.
Topics: Chemoprevention; Humans; Migraine Disorders; Pharmacogenomic Variants; Polymorphism, Single Nucleoti | 2021 |
Evaluating Quality of Life in Patients With Meniere's Disease Treated as Migraine.
Topics: Chemoprevention; Female; Fructose; Humans; Male; Meniere Disease; Middle Aged; Migraine Disorders; N | 2018 |
Can verapamil be effective in controlling vertigo and headache attacks in vestibular migraine accompanied with Meniere's disease? A preliminary study.
Topics: Adult; Calcium Channel Blockers; Female; Headache; Humans; Male; Meniere Disease; Middle Aged; Migra | 2019 |
A Young Woman With A History of Stroke and Recurrent Migraine Headaches.
Topics: Adult; Anti-Arrhythmia Agents; Biopsy; CADASIL; Female; Humans; Magnetic Resonance Imaging; Migraine | 2019 |
Management of mal de debarquement syndrome as vestibular migraines.
Topics: Adult; Aged; Drug Therapy, Combination; Female; Fructose; Genetic Predisposition to Disease; Humans; | 2017 |
Review of pediatric migraine headaches refractory to medical management.
Topics: Adolescent; Amitriptyline; Analgesics, Non-Narcotic; Biofeedback, Psychology; Child; Female; Follow- | 2009 |
Coexisting trigeminal autonomic cephalalgias and hemicrania continua.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Anticonvulsants; Brain; Calcium Channel Blockers; Cl | 2010 |
Resolution of visual field constriction with verapamil in a patient with bilateral optic neuropathy, migraine and Raynaud's phenomenon.
Topics: Adult; Female; Humans; Migraine Disorders; Optic Nerve Diseases; Raynaud Disease; Treatment Outcome; | 2009 |
Non-ionic contrast media induces oxidative stress and apoptosis through Ca²⁺ influx in human neutrophils.
Topics: Adult; Apoptosis; beta Carotene; Boron Compounds; Calcium; Calcium Channel Blockers; Caspases; Cells | 2012 |
Cerebral vasoconstriction and stroke after use of serotonergic drugs.
Topics: Cerebrovascular Circulation; Humans; Migraine Disorders; Serotonin Agents; Stroke; Vasoconstriction; | 2002 |
Migraine with cranial autonomic features and strict unilaterality.
Topics: Adult; Autonomic Pathways; Calcium Channel Blockers; Cluster Headache; Female; Functional Laterality | 2003 |
Hemicrania continua with contralateral episodic cluster headache: a case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cluster Headache; Functional Laterality; Humans; Ind | 2003 |
Rebound abdominal pain: noncephalic pain in abdominal migraine is exacerbated by medication overuse.
Topics: Abdominal Pain; Adult; Age Factors; Analgesics, Opioid; Calcium Channel Blockers; Dose-Response Rela | 2008 |
Calcium channel blockers and migraine.
Topics: Humans; Migraine Disorders; Nicotinic Acids; Nimodipine; Verapamil | 1984 |
[Cluster headache: misjudged because unknown].
Topics: Adult; Analgesics; Calcium Channel Blockers; Cluster Headache; Diagnosis, Differential; Humans; Male | 1997 |
Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
Topics: Administration, Sublingual; Adult; Aged; Blood Pressure; Calcium Channel Blockers; Female; Headache; | 1999 |
The effect of intravenous verapamil on cerebral hemodynamics in a migraine patient with hemiplegia.
Topics: Adult; Calcium Channel Blockers; Cerebrovascular Circulation; Female; Hemiplegia; Hemodynamics; Huma | 2000 |
Simultaneous occurrence of ipsilateral cluster headache and chronic paroxysmal hemicrania: a case report.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Chronic Disease; Cluster Headache; Humans; Indometha | 2000 |
Migraine in older patients: a case report and management strategies.
Topics: Acetaminophen; Aged; Aged, 80 and over; Antipyrine; Cheese; Chloral Hydrate; Diagnosis, Differential | 2000 |
Is it migraine or cluster?
Topics: Adult; Calcium Channel Blockers; Cluster Headache; Diagnosis, Differential; Female; Humans; Migraine | 2000 |
Hemiplegic migraine induced by exertion.
Topics: Aged; Brain Ischemia; Calcium Channel Blockers; Diagnosis, Differential; Exercise; Hemiplegia; Human | 2000 |
Intravenous verapamil in acute migraine with prolonged aura.
Topics: Acute Disease; Humans; Injections, Intravenous; Male; Middle Aged; Migraine Disorders; Verapamil | 1992 |
Ipsilateral cluster headache and chronic paroxysmal hemicrania: two case reports.
Topics: Adult; Chronic Disease; Cluster Headache; Drug Therapy, Combination; Humans; Indomethacin; Male; Mid | 1992 |
5-Hydroxtryptamine1D receptor agonism predicts antimigraine efficacy.
Topics: Adenylyl Cyclase Inhibitors; Amitriptyline; Animals; Cattle; Caudate Nucleus; Dihydroergotamine; Erg | 1991 |
Shock in a woman with chronic pain.
Topics: Adult; Bradycardia; Calcium; Female; Humans; Hypotension; Migraine Disorders; Pain, Postoperative; V | 1991 |
A possible relationship between migraine and coronary artery spasm.
Topics: Coronary Disease; Coronary Vasospasm; Electrocardiography; Female; Humans; Middle Aged; Migraine Dis | 1986 |
[Use of calcium-antagonist drugs in the preventive therapy of migraine. Experience with verapamil].
Topics: Adolescent; Adult; Female; Humans; Male; Middle Aged; Migraine Disorders; Verapamil | 1987 |
[Use of verapamil in the treatment of migraine].
Topics: Adult; Female; Humans; Middle Aged; Migraine Disorders; Verapamil | 1987 |
[Preventive therapy of migraine: flunarizine versus verapamil].
Topics: Adult; Cinnarizine; Female; Flunarizine; Humans; Male; Middle Aged; Migraine Disorders; Random Alloc | 1985 |
Management of the migraine patient.
Topics: Amitriptyline; Analgesics; Diagnosis, Differential; Diet; Ergotamine; Humans; Hypnotics and Sedative | 1986 |
Pupillary and vascular effects of calcium antagonists in migraine.
Topics: Blood Pressure; Calcium Channel Blockers; Cinnarizine; Flunarizine; Humans; Migraine Disorders; Nife | 1985 |